Original
Uso de terapia antihiperglucemiante con beneficio cardiovascular en pacientes con diabetes tipo 2 que requieren hospitalización: un estudio transversal
Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study
J. Enaa,
, J. Carretero-Gómezb, A. Zapatero-Gaviriac, F.J. Carrasco Sánchezd, M. del Romero-Sánchezc, C. González-Becerrae, J.C. Blazquez-Encinarf, M.J. Iguzquiza-Pellejerog, B. de Escalante Yangüelah, R. Gómez-Huelgasi, en representación del Grupo de Trabajo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna ◊
Corresponding author
a Servicio de Medicina Interna, Hospital Marina Baixa, Villajoyosa, Alicante, España
b Servicio de Medicina Interna, Hospital de Zafra, Zafra, Badajoz, España
c Servicio de Medicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España
d Servicio de Medicina Interna, Hospital Universitario Juan Ramón Jiménez, Huelva, España
e Servicio de Medicina Interna, Hospital San Juan de Dios, Tenerife, España
f Servicio de Medicina Interna, Hospital Universitario de Torrevieja, Torrevieja, Alicante, España
g Servicio de Medicina Interna, Hospital Reina Sofía, Tudela, Navarra, España
h Servicio de Medicina Interna, Hospital Clínico Lozano Blesa, Zaragoza, España
i Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Málaga, España
Ver másInvestigadores del Grupo de Trabajo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna
Read
1990
Timeswas read the article
150
Total PDF
1840
Total HTML
Article information
ISSN: 00142565Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2026 3 | 57 | 0 | 57 |
| 2026 2 | 127 | 0 | 127 |
| 2026 1 | 151 | 0 | 151 |
| 2025 12 | 127 | 0 | 127 |
| 2025 6 | 3 | 0 | 3 |
| 2025 5 | 52 | 1 | 53 |
| 2025 4 | 65 | 0 | 65 |
| 2025 3 | 45 | 0 | 45 |
| 2025 2 | 31 | 0 | 31 |
| 2025 1 | 28 | 0 | 28 |
| 2024 12 | 26 | 0 | 26 |
| 2024 11 | 19 | 0 | 19 |
| 2024 10 | 29 | 0 | 29 |
| 2024 9 | 23 | 0 | 23 |
| 2024 8 | 19 | 0 | 19 |
| 2024 7 | 23 | 0 | 23 |
| 2024 6 | 19 | 0 | 19 |
| 2024 5 | 20 | 2 | 22 |
| 2024 4 | 13 | 0 | 13 |
| 2024 3 | 15 | 2 | 17 |
| 2024 2 | 14 | 0 | 14 |
| 2024 1 | 18 | 1 | 19 |
| 2023 12 | 24 | 0 | 24 |
| 2023 11 | 35 | 0 | 35 |
| 2023 10 | 23 | 0 | 23 |
| 2023 9 | 34 | 3 | 37 |
| 2023 8 | 18 | 2 | 20 |
| 2023 7 | 21 | 0 | 21 |
| 2023 6 | 22 | 5 | 27 |
| 2023 5 | 28 | 6 | 34 |
| 2023 4 | 21 | 0 | 21 |
| 2023 3 | 38 | 4 | 42 |
| 2023 2 | 22 | 6 | 28 |
| 2023 1 | 29 | 2 | 31 |
| 2022 12 | 25 | 0 | 25 |
| 2022 11 | 41 | 0 | 41 |
| 2022 10 | 26 | 4 | 30 |
| 2022 9 | 26 | 2 | 28 |
| 2022 8 | 30 | 2 | 32 |
| 2022 7 | 28 | 3 | 31 |
| 2022 6 | 29 | 2 | 31 |
| 2022 5 | 17 | 3 | 20 |
| 2022 4 | 31 | 10 | 41 |
| 2022 3 | 49 | 3 | 52 |
| 2022 2 | 38 | 5 | 43 |
| 2022 1 | 27 | 2 | 29 |
| 2021 12 | 44 | 0 | 44 |
| 2021 11 | 62 | 16 | 78 |
| 2021 10 | 3 | 4 | 7 |
| 2021 6 | 1 | 2 | 3 |
| 2021 4 | 46 | 16 | 62 |
| 2021 3 | 1 | 0 | 1 |
| 2021 1 | 1 | 0 | 1 |
| 2020 12 | 6 | 4 | 10 |
| 2020 10 | 1 | 2 | 3 |
| 2020 9 | 5 | 4 | 9 |
| 2020 8 | 4 | 4 | 8 |
| 2020 7 | 4 | 4 | 8 |
| 2020 6 | 2 | 2 | 4 |
| 2020 5 | 3 | 4 | 7 |
| 2020 4 | 51 | 18 | 69 |
Show all
